Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019 (COVID-19). In silico docking and molecular dynamics studies have shown ...
Drugs that target opioid receptors sometimes have severe side effects. Thousands of people around the world die every day from overdoses involving opioids such as fentanyl. An international team of ...
Rystiggo (rozanolixizumab) is a brand-name subcutaneous infusion that’s prescribed for myasthenia gravis. Rystiggo has interactions with some other drugs. Examples include immunoglobulins and ...
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and ...
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center Androgen receptor pathway ...
A new study has revealed the mechanism of multimerization — the association of different molecules to form complex structures ...
A new experimental compound, RAGE406R, prevented heart, kidney, and tissue damage caused by diabetes by blocking a harmful ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback